List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 149 studies with search of:   "Ezetimibe"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Comparison of Ezetimibe Plus Simvastatin Versus Ezetimibe or Simvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03757)(COMPLETED)
Condition: Hypercholesterolemia
Interventions: Drug: Ezetimibe + Simvastatin;   Drug: Simvastatin;   Drug: Ezetimibe
2 Completed Pharmacokinetic Drug Interaction Between Ezetimibe and Tacrolimus After Single Dose Administration in Healthy Subjects
Conditions: Pharmacokinetics;   Drug Interactions;   Hypercholesterolemia;   Immunosuppression
Interventions: Drug: 1 tablet Ezetrol(R) (ezetimibe), MSD Sharp & Dohme GmbH, Germany;   Drug: 1 capsule Prograf(R) (tacrolimus), Astellas Pharma GmbH, Germany;   Drug: 1 tablet Ezetrol(R) + 1 capsules Prograf(R)
3 Completed Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects
Conditions: Pharmacokinetics;   Drug Interactions;   Hypercholesterolemia;   Immunosuppression
Interventions: Drug: 1 tablet Ezetrol(R) (ezetimibe), MSD Sharp & Dohme GmbH, Germany;   Drug: 1 tablet Rapamune(R) (sirolimus), Wyeth Pharma, Germany;   Drug: 1 tablet Ezetrol(R) + 1 tablet Rapamune(R)
4 Completed Assessment of Potential Interaction Between Ezetimibe and Rosuvastatin in Healthy Subjects With High Cholesterol (P03317)(COMPLETED)
Conditions: Hypercholesterolemia;   Atherosclerosis
Interventions: Drug: Ezetimibe + Rosuvastatin;   Drug: Rosuvastatin;   Drug: Placebo;   Drug: Ezetimibe
5 Completed Efficacy of TAK-475 Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.
Condition: Hypercholesterolemia
Interventions: Drug: Lapaquistat;   Drug: Lapaquistat and ezetimibe;   Drug: Ezetimibe
6 Not yet recruiting Pharmacokinetic and Pharmacodynamic Interactions Between the Cholesterol-Lowering Ezetimibe and the Non-Nucleoside Reverse Transcriptase Inhibitor Efavirenz During Chronic Treatment in Healthy Volunteers With Reference to Intestinal Expression of CYP3A4, UGT1A1, ABCB1 and ABCC2
Conditions: Pharmacokinetics;   Drug Interactions;   Pharmacodynamics;   Intestinal Transporter Expression
Interventions: Drug: 1 tablet Ezetrol(R) (ezetimibe), MSD Sharp & Dohme GmbH, Germany;   Drug: 1 tablet Ezetrol(R) + 2 capsules Sustiva(R) (efavirenz) single dose, DuPont Pharma;   Drug: tablet Ezetrol(R) and 2 capsules Sustiva(R) steady state
7 Completed Evaluation of Low-Density Lipoprotein (LDL) Cholesterol Levels in Patients Switched From Zetia 10 Milligrams to 5 Milligrams
Condition: Hypercholesterolemia
Interventions: Drug: Ezetimibe 10 mg;   Drug: Ezetimibe 5 mg
8 Enrolling by invitation A 12-Week Post-Marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-Lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05244)
Conditions: Hypercholesterolemia;   Familial Hypercholesterolemia;   Homozygous Sitosterolemia
Interventions: Drug: Ezetimibe;   Drug: Ezetimibe + other lipid-lowering medication(s)
9 Enrolling by invitation A 52-Week Post-Marketing, Observational Study to Confirm the Safety and Efficacy of Zetia Alone or in Combination With Other Lipid-Lowering Drugs in Japanese Subjects With Hypercholesterolemia (Study P05245)
Conditions: Hypercholesterolemia;   Familial Hypercholesterolemia;   Homozygous Sitosterolemia
Interventions: Drug: Ezetimibe;   Drug: Ezetimibe + other lipid-lowering medication(s)
10 Recruiting A Study of Ezetimibe Added On to Rosuvastatin Versus Up Titration of Rosuvastatin in Patients With Hypercholesterolemia
Condition: Hypercholesterolemia
Interventions: Drug: Comparator: rosuvastatin 5 mg + ezetimibe 10 mg;   Drug: Comparator: rosuvastatin 10 mg;   Drug: Comparator: rosuvastatin 10 mg + ezetimibe 10 mg;   Drug: Comparator: rosuvastatin 20 mg
11 Completed Effectiveness and Safety of Ezetimibe Added to Atorvastatin in Patients With High Cholesterol and Coronary Heart Disease (Study P03740)(COMPLETED)
Conditions: Hypercholesterolemia;   Coronary Heart Disease
Interventions: Drug: ezetimibe;   Drug: placebo
12 Completed To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia
Condition: Hypercholesterolemia
Interventions: Drug: Comparator: ezetimibe/simvastatin + niacin (ER);   Drug: Comparator: Placebo to ezetimibe/simvastatin;   Drug: Comparator: niacin (ER) tablet;   Drug: Comparator: ezetimibe (+) simvastatin;   Drug: Comparator: Placebo to Niacin (ER)
13 Completed Safety and Efficacy Study Comparing ABT-335 in Combination With Atorvastatin and Ezetimibe to Atorvastatin in Combination With Ezetimibe in Subjects With Abnormal Lipid (Fat) Levels in the Blood
Conditions: Dyslipidemias;   Coronary Heart Disease;   Combined (Atherogenic) Dyslipidemia;   Mixed Dyslipidemia
Interventions: Drug: ABT-335;   Drug: placebo;   Drug: atorvastatin;   Drug: ezetimibe
14 Completed Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With High Cholesterol (P03434)
Conditions: Hypercholesterolemia;   Atherosclerosis
Interventions: Drug: Ezetimibe + Atorvastatin;   Drug: Atorvastatin
15 Completed Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435)(COMPLETED)
Conditions: Hypercholesterolaemia;   Atherosclerosis
Interventions: Drug: Ezetimibe + Simvastatin;   Drug: Simvastatin
16 Completed Effects of Ezetimibe on the Absorption of Oxidized Cholesterol
Condition: Hypercholesterolemia
Intervention: Drug: ezetimibe
17 Active, not recruiting Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)
Condition: Peripheral Arterial Disease
Interventions: Drug: Ezetimibe;   Drug: Niaspan;   Drug: Statin therapy;   Behavioral: Standard care;   Drug: Aspirin;   Drug: Clopidogrel;   Drug: Placebo Niaspan;   Drug: Placebo Ezetimibe;   Procedure: Percutaneous transluminal angioplasty (PTA)
18 Completed Effect Of Ezetimibe Coadministration With Simvastatin In A Middle Eastern Population: A Prospective, Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial
Condition: Hypercholesterolemia
Interventions: Drug: ezetimibe;   Drug: simvastatin;   Drug: Placebo (Unspecified)
19 Terminated Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405)(TERMINATED)
Conditions: Hypercholesterolemia;   Atherosclerosis
Interventions: Drug: Ezetimibe;   Drug: Placebo
20 Completed Higher-Dose Ezetimibe to Treat Homozygous Sitosterolemia
Conditions: Heart Diseases;   Metabolism, Inborn Errors
Interventions: Drug: SCH-58235;   Drug: Ezetimibe

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services